Latest news

Researchers and Labour Reform

Activatable Antibodies in Targeted Therapies

Brain Glycogen and Neurodegenerative Diseases

Interview with Oriol Martínez Huguet, CEO of GasN2

IQS Teaches its First Bioprocesses Course for Companies

7 QUESTIONS FOR… Gilda Hernández

Hausmann, New Member of the IQS Business Foundation

Introducing Our New Website!
Check our upcoming events
